Iqvia Holdings (IQV) Total Liabilities (2011 - 2026)
Iqvia Holdings' (IQV) quarterly Total Liabilities came in at $23.6 billion in Q2 2026, up 3.21% year-over-year from $22.8 billion in Q2 2025, and up 1.09% quarter-over-quarter from $23.3 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Total Liabilities (2011 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Total Liabilities across 16 years of filings, most recently posting $23.6 billion for Q2 2026.
- In Q2 2026, Total Liabilities rose 3.21% year-over-year to $23.6 billion; the TTM figure through Jun 2026 stood at $23.6 billion (up 3.21% YoY), while the FY2025 annual figure was $23.3 billion, up 11.91% from the prior year.
- Total Liabilities came in at $23.6 billion for Q2 2026 at Iqvia Holdings, up from $23.3 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $23.6 billion in Q2 2026 to a low of $18.9 billion in Q3 2022.
- Average Total Liabilities over 5 years is $20.8 billion, with a median of $20.3 billion recorded in 2023.
- Year-over-year, Total Liabilities declined 2.98% in 2024 and increased 16.06% in 2025.
- Over 5 years, Total Liabilities stood at $19.6 billion in 2022, then grew by 5.09% to $20.6 billion in 2023, then rose by 1.28% to $20.8 billion in 2024, then increased by 11.91% to $23.3 billion in 2025, then gained by 1.14% to $23.6 billion in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $23.6 billion in Q2 2026, $23.3 billion in Q1 2026, and $23.3 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 23.58 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.62 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 7.02 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 4.64 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.19 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.06 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 569.76 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 28.83 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 7.47 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 6.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.58 Bn |
| Mar 31, 2026 | 23.33 Bn |
| Dec 31, 2025 | 23.31 Bn |
| Sep 30, 2025 | 22.44 Bn |
| Jun 30, 2025 | 22.85 Bn |
| Mar 31, 2025 | 21.34 Bn |
| Dec 31, 2024 | 20.83 Bn |
| Sep 30, 2024 | 20.21 Bn |
| Jun 30, 2024 | 19.68 Bn |
| Mar 31, 2024 | 20.23 Bn |
| Dec 31, 2023 | 20.57 Bn |
| Sep 30, 2023 | 20.17 Bn |
| Jun 30, 2023 | 20.29 Bn |
| Mar 31, 2023 | 19.81 Bn |
| Dec 31, 2022 | 19.57 Bn |
| Sep 30, 2022 | 18.88 Bn |
| Jun 30, 2022 | 19.06 Bn |
| Mar 31, 2022 | 19.05 Bn |
| Dec 31, 2021 | 18.65 Bn |
| Sep 30, 2021 | 18.20 Bn |